Biktarvy 50-200-25 MG tablet UU 30S
Ended Awarded Last action
- Contract number
- SPE2DR26FQV5U
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $82,697
Award facts
- Contract value 100% obligated
- $82,696.56 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $82,696.56 to AmerisourceBergen Drug Corp for the supply of BIKTARVY 50-200-25 mg tablets (30-count units), with an ultimate completion date of January 30, 2026. This competitively awarded, firm fixed-price contract carries no set-aside designation and is being performed at the contractor's facility in Conshohocken, Pennsylvania. BIKTARVY is an antiretroviral medication used in the treatment of human immunodeficiency virus (HIV), reflecting the Defense Logistics Agency Medical Supply Chain's ongoing procurement of pharmaceutical products to support military healthcare operations.
This delivery order operates under AmerisourceBergen Drug Corp's parent company, Cencora, Inc., which holds a significant Indefinite Delivery Contract with the DLA Troop Support Medical valued at up to $999,999,999.00 and extending through December 31, 2031. This prime vehicle enables comprehensive delivery of pharmaceutical products, medical supplies, specialty medications, vaccines, and related healthcare commodities to support military treatment facilities and defense healthcare programs globally. AmerisourceBergen Drug Corp's role as a major pharmaceutical distributor and critical federal medical vendor demonstrates its capacity to fulfill the Defense Logistics Agency's essential pharmaceutical procurement requirements across multiple therapeutic domains for military and veteran healthcare systems.
Quick answers
Who was awarded contract SPE2DR26FQV5U?
SPE2DR26FQV5U was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 29, 2026.
How much is contract SPE2DR26FQV5U worth?
The government has obligated $82,697 on SPE2DR26FQV5U.
Is contract SPE2DR26FQV5U an order under another contract?
Yes. SPE2DR26FQV5U is a delivery order under SPE2DR25D1022, an indefinite delivery contract.
Was contract SPE2DR26FQV5U competed?
The extent of competition for SPE2DR26FQV5U was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award